CHGB · Partner-reported service scope
Personalised Health Assessment
Chronic food sensitivity, hair nutrient and toxic element screening, allergen-specific antibody testing and NAD+ optimisation.
- Partner-reported scope
- 240+ assessment items
- Method
- IgG panels · hair element analysis · NAD+
CHGB · Partner-reported
Service capabilities
The following scope is reported by the partner. Quantities describe the partner portfolio and do not represent VectorGene’s own track record.
- Chronic food sensitivity
- 200+ item IgG-based panel.
- Hair nutrient screening
- 17 nutritional elements.
- Toxic element screening
- 9 toxic elements including lead, arsenic, mercury and cadmium.
- Allergen-specific antibodies
- Inhalant and food allergen groups.
- NAD+ testing and optimisation
- Levels, supplementation efficacy, dosage, absorption curve.
Explore services in this category.
Read each service’s complete scope and regulatory note. These links help you explore the portfolio; programme-specific suitability requires feasibility assessment.
Link each assessment to a justified use.
A combined health assessment needs a clear scope for every component. Explain which information is descriptive, which supports an established clinical question and which remains exploratory. The proposed report should make these distinctions understandable before the institution decides how the service fits its care pathway.
Genetic results are interpreted alongside the test’s purpose and personal and family history. A negative result can leave questions unresolved, and an uncertain variant does not establish or exclude a diagnosis.
MedlinePlus Genetics: What do the results of genetic tests mean?The international microbiome-testing consensus identifies limited evidence for clinical usefulness and calls for clear indications, validated methods and transparent reporting. A descriptive microbiome profile should be distinguished from a proven clinical decision tool.
Porcari and colleagues · The Lancet Gastroenterology & Hepatology: International consensus statement on microbiome testing in clinical practiceExternal references explain the wider context. They do not verify or endorse the supplied VectorGene or partner offering.
Questions for the programme brief
What is included and why?
List the proposed tests, intended uses and evidence for combining their findings in one assessment.
How are uncertain findings handled?
Review interpretation boundaries, clinical review, counselling and referral rather than promise a definitive health forecast.
Who owns the next step?
Identify the qualified reviewer and distinguish appropriate follow-up from unsupported recommendations.
What to prepare for review
- Component test list and intended uses
- Evidence and reporting limitations
- Clinical review and referral pathway
Working environments
Clinical information and laboratory context.
Illustrative stock photography provides context for the people, processes and working environments behind this capability.
